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Abstract
Background: The p53 signalling pathway has hundreds of inputs and outputs. It can trigger cellular senescence, cell-
cycle arrest and apoptosis in response to diverse stress conditions, including DNA damage, hypoxia and nutrient 
deprivation. Signals from all these inputs are channeled through a single node, the transcription factor p53. Yet, the 
pathway is flexible enough to produce different downstream gene expression patterns in response to different 
stresses.
Results: We construct a mathematical model of the negative feedback loop involving p53 and its inhibitor, Mdm2, at 
the core of this pathway, and use it to examine the effect of different stresses that trigger p53. In response to DNA 
damage, hypoxia, etc., the model exhibits a wide variety of specific output behaviour - steady states with low or high 
levels of p53 and Mdm2, as well as spiky oscillations with low or high average p53 levels.
Conclusions: We show that even a simple negative feedback loop is capable of exhibiting the kind of flexible stress-
specific response observed in the p53 system. Further, our model provides a framework for predicting the differences 
in p53 response to different stresses and single nucleotide polymorphisms.
Background
The tumor suppressor protein, p53, is a transcription fac-
tor that regulates the activity of hundreds of genes
i n v o l v e d  i n  c e l l  g r o w t h  a n d  d e a t h  [ 1 , 2 ] .  O v e r  5 0 %  o f
human cancer cells contain mutations in p53, because of
which it has become a key target in cancer research [3]. A
wide variety of stress conditions result in the accumula-
tion and activation of p53 - among others: DNA damage,
hypoxia, heat shock, nutrient deprivation and oncogene
activation. Despite the fact that all these inputs are inte-
grated into a single node, p53, the expression pattern of
downstream genes (and hence the physiological
response) appears to be specific to each stress. For exam-
ple, hypoxia invariably leads to apoptosis [4], whereas
ribonucleotide depletion leads to reversible cell cycle
arrest [5], and UV irradiation can result in either cell
cycle arrest or apoptosis depending on the intensity of the
damage [6].
How does the regulatory network around p53 retain
this exibility even though all inputs converge at a single
node? We argue in this paper that the particular design of
the p53-Mdm2 feedback loop at the core of this network
could be the source of this flexibility. p53 is regulated by
other proteins at two levels: its stability (e.g., Pirh2,
COP1, Mdm2 decrease its half-life [7-9]), and its activity
as a transcription factor (e.g., MdmX, Mdm2 retard its
activity [10]). We focus on Mdm2 because (a) Mdm2 null
mutants are lethal in early development in mice [11], and
(b) Mdm2 directly regulates both activity and stability of
p53. Mdm2 is an E3 ligase that binds to p53. Mono-ubiq-
uitination of p53 by Mdm2 inhibits its transcriptional
activity, while poly-ubiquitination triggers its degradation
[12]. In turn, the mdm2 gene is activated by p53, thus
forming a negative feedback loop [13]. We use a mathe-
matical model of the p53-Mdm2 feedback loop to dem-
onstrate how multiple inputs can be integrated with
sufficient discrimination in such a feedback loop to allow
diverse, yet specific, output behaviour. Using the model,
we can predict which input stresses will produce the
stronger p53 response, as well as the effect of single nuce-
lotide polymorphisms (in particular the SNP309 on
mdm2) on the p53 response.
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Methods
A model of the p53-Mdm2 negative feedback loop
Our model focuses on the following four concentrations:
nuclear-p53, p; Mdm2, m; Mdm2 mRNA, mm; and the
p53-Mdm2 complex, c. The temporal dynamics of these
components of the model are specified by four differen-
tial equations:
The model is provided in SBML format as additional
file 1 and in the Biomodels database: http://www.ebi.ac.
uk/biomodels-main, model number 1006280000.
Figure 1 shows the interactions that correspond to each
of the mathematical terms in the above equations. Table 1
lists the parameters of the model and their default values.
Some parameters correspond to specific processes (e.g.
Mdm2-mediated degradation of p53 (δ), activation of
mdm2  by p53 (kt)). Others are "effective" parameters
which model the combined action of several proteins that
all affect p53 or Mdm2. For example, α models all Mdm2-
independent processes which result in the reduction of
the active p53 concentration in the nucleus: spontaneous
degradation, export out of the nucleus, physical interac-
tion with other proteins, sequestration in the cytoplasm
(e.g. by Pirh2), modifications which prevent activity, etc.
We also assume that activation of mdm2 by p53 has an
associated Hill coefficient of 2 (there is a double binding
site for p53 at the Mdm2 promotor [14]), and that the
half-life of Mdm2 is independent of whether it is free or
bound to p53 (ref. [15] shows the latter is true in the
absence of stress). Details on how parameter values were
chosen are provided in additional file 2.
Most previous models have used an explicit time delay
to model transcription and translation (for example, see
[16-18]). In these models, the time delays are essential for
producing oscillatory behaviour of p53 concentration.
Mathematically, the use of explicit time delays converts
the equations into delay differential equations which have
effectively infinite dimensions and are well known to
often exhibit oscillatory behaviour. In contrast our model
has no explicit time delay. Thus, the cause of oscillations
in our model is completely different; they occur due to
the nonlinearities introduced by complex formation
between p53 and Mdm2. Other models [19,20] have
avoided explicit time delays but used multiple feedback
loops, whereas our model uses a single negative feedback
loop. [21] has explored a range of different models to
reproduce the behaviour under gamma irradiation. Of
these, one model, IV, is closest to our model in that it uses
a nonlinear degradation of p53 instead of explicit time
delays to produce oscillations. However, the molecular
mechanism behind this nonlinearity was not discussed.
Our model shows that the complex formation between
p53 and Mdm2 is sufficient for generating nonlinearities
that lead to oscillations. Finally, the main purpose of this
paper, to investigate response specificity to different
stresses has not, to our knowledge, been studied in any
previous model.
Results and Discussion
p53 dynamics in the presence and absence of stress
This model system of a negative feedback loop shows
plenty of variety in output behaviour. Depending on the
values of parameters, the system is capable of steady state
solutions with any combination of high or low p53 and
Mdm2, as well as oscillations with high or low average
p53. Figure 2A shows four examples: a steady state
response and oscillations with differing amplitudes and
periods. The oscillations are typically spiky, but smooth
oscillations can also be generated.
Ideally, we would like to correlate each of these output
states of the pathway to specific physiological responses
like cell cycle arrest or apoptosis. Clearly, the level of p53
is an important determinant of the response [6,22,23],
and the presence or absence of oscillations is also likely to
dp
dt
pk p mk c c fb =− − + + sa g (1)
dmm
dt
kp m tm =−
2 b (2)
dm
dt
km kp m kc m tl m f b =− + + − dg c (3)
dc
dt
kp m kc c fb =− − − dg c (4)
Figure 1 Schematic representation of the model. The figure shows, 
schematically, the components and interactions included in the mod-
el. Transcription of mdm2 and subsequent translation to the Mdm2 
protein are described by the rate constants kt and ktl, respectively. β 
represents the rate of spontaneous degradation of the Mdm2 mRNA. 
Two rate constants describe complex formation (kf) and breakup (kb). 
p53 is assumed to be produced at a constant rate σ. Degradation of 
p53 occurs at the rate δ when it is Mdm2-mediated, and at the rate α 
when it is Mdm2-independent. Finally, we assume that the Mdm2 deg-
radation rate, γ, is independent of whether it is bound to p53 or not.
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be related to the physiological behaviour [2,24]. When
there are oscillations, some downstream genes may
respond to the peak p53 level, while others may sense the
average level. This depends on the association and disso-
ciation rates of p53 to the relevant operators (this has
been discussed in the context of the transcription factor
NF-kB in ref. [25], and the same principle would apply to
p53). Further, in some cases the response may depend on
the activity of p53 as well as its level [22,26]. In sum, not
enough information exists to make a precise link between
the molecular state and the physiological response. How-
ever, it is reasonable to expect that large increases in p53
levels would correlate with a higher incidence of apopto-
sis, whereas low or moderate increases would correlate
with less drastic responses such as cell cycle arrest.
Therefore, we have elected to discuss the response in
terms of the p53 level. In the figures below we have
shown the peak p53 level. Similar figures with average
p53 level, and the ratio between free and bound p53 are
shown in Figures S3 and S4 of additional file 2.
In the absence of stress, p53 levels are typically main-
tained quite low. For this, a sufficient Mdm2 level is
required to keep the half-life of p53 short. Thus, in a typi-
cal "resting" state there is a fairly high turnover of p53.
The area shaded in green and blue in Figures 2B-D shows
parameter combinations which satisfy these conditions -
a low level of p53 and no oscillations. The white dot, the
default resting state of the cell, before it is subjected to
any stress, was chosen to lie within this blue-green region
of parameter space (see Table 1 for the corresponding
parameter values). Of course, the precise levels of con-
centration, and turnover rates, in the resting state can
vary from cell to cell, both because of variability in levels
of various proteins, as well as the presence of mutations,
such as single-nucleotide polymorphisms. We will return
to this point later in the paper.
Specific response to four stresses
The system can be triggered by numerous stresses. We
model different stresses as affecting different parameter
combinations, as shown in Table 1. Figure 2A shows the
diversity in response to different stresses, starting from
the same resting state. From Figures 2B-D it already
becomes apparent that the level of p53 is more sensitive
to changes in δ and kt than to the p53-Mdm2 dissociation
constant kD = kb/kf. Most stresses, however, affect more
than one parameter.
A particularly simple, though "artificial", stress is the
introduction of Nutlin. Nutlin reduces the binding of
Mdm2 to p53, while leaving its other properties
unchanged. Nutlin treatment can trigger cell cycle arrest,
but not apoptosis [27,28]. This is consistent with our
model's prediction that increasing kD  (weakening the
binding) alone causes a very modest increase in p53 levels
(Figures 2A and 2D).
A more common real-world stress is DNA damage,
which can trigger processes that result in (a) increased
auto-ubiquitination of Mdm2, (b) decreased ubiquitina-
tion of p53 by Mdm2 and (c) weaker binding of p53-
Mdm2 [15,29,30], corresponding in our model to increas-
Table 1: Model parameters
Parameter Default value Effect of stresses
σ p53 production 1000 nM.hr-1 Ribonucleotide depletion â
α Mdm2-independent 0.1 hr-1
degradation/deactivation of p53
δ Mdm2-dependent 11 hr-1 DNA damage, Hypoxia,
degradation/deactivation of p53 Oncogene, Nitric Oxide: all ä
kt Mdm2 transcription 0.03 nM-1hr-1 Hypoxia ä
ktl Mdm2 translation 1.4 hr-1
B Mdm2 mRNA degradation 0.6 hr-1
γ degradation/deactivation of Mdm2 0.2 hr-1 DNA damage â
kb p53-Mdm2 dissociation 7200 hr-1
kD = kb/kf p53-Mdm2 dissociation constant 1.44 nM Nutlin â, DNA damage â
The numbers show the default value of each parameter, and correspond to the default resting state marked by the white dot in Figure 2. The 
rightmost column shows which stresses increase (upward arrow) or decrease (downward arrow) the value of a parameter. Details of the 
choice of parameter values are given in additional file 2.Hunziker et al. BMC Systems Biology 2010, 4:94
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ing γ, decreasing δ, and increasing kD. Single-cell experi-
ments have found that irradiation of various types
t r i g g e r s  o s c i l l a t i o n s  i n  p 5 3  l e v e l s  w i t h  a  p e r i o d  o f  5 - 6
hours. The parameter changes used to mimic DNA dam-
age stress were chosen such that the response matches
the observations of Ref. [31] which found that, in
response to ionizing radiation, the first p53 peak occured
at around 30 min, the second at 6 hours and the third
between 9 and 13 hours. The damping of the amplitude
also matches the observations which found the second
peak to be around half as high as the first, and the third to
be around 2.5 times lower than the first [31]. A similar
response is seen when gamma radiation is used to induce
D N A  d a m a g e  [ 2 1 ] .  W h e n  w e  i n c r e a s e  kD and  γ, while
lowering  δ, corresponding to the molecular processes
described above, our model produces an oscillatory solu-
tion in accordance with the experimental observations
(see Figure 2A).
Hypoxia is another stress that increases p53 levels. It is
known that under hypoxic conditions, even though p53
accumulates, it does not possess its transactivation prop-
erty [4,32], i.e., kt is decreased. This means that Mdm2 is
down-regulated. Furthermore, hypoxia induces HIF
which binds to p53 and prevents degradation [33], which
we mimic by decreasing δ. Hypoxia does not lead to cell-
cycle arrest, suggesting that it typically results in much
higher levels of p53. Consistent with this picture, our
model yields a stronger response (i.e., oscillations with a
Figure 2 p53 dynamics. A: Time dependence of the p53 concentration after application of different cellular stresses at time zero. B-D: The colors 
show peak concentration of free p53, after the system has settled into a steady-state or stable oscillations (note that the peak level differs from the 
average only when there are oscillations), as a function of two model parameters. The white line marks where the spikyness (amplitude/average [25]) 
of p53 oscillations becomes equal to 2 (i.e., where the amplitude becomes twice the average). Thus, spiky oscillations occur to the right of the line in 
(B) and (D), and to the left in (C). The white dot shows the parameters corresponding to the default resting state (see Table 1). Black arrows illustrate 
the change in parameters we impose on the system to model the respective stresses.
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bigger amplitude and larger average p53 level) when we
apply a hypoxic stress when compared to other stresses
with similar fold-changes in parameter values (see Figure
2A).
Deregulated  oncogenes  are another signal that can
trigger the p53 pathway. They lead to increased transcrip-
tion of ARF , which binds to Mdm2 and inhibits its E3
ligase activity [34]. This corresponds to decreasing δ, the
Mdm2-dependent degradation of p53. The response to
this, in our model, is oscillations in p53 but weaker than
the response to DNA damage or hypoxia (see Figure 2).
Predicting the relative strength of the response to different 
stresses
Figure 3 shows the relative effect on the average free p53
level when each parameter of the model is varied from its
default value, keeping the values of all other parameters
fixed. The slope of each curve is a measure of how sensi-
tive the p53 level is to changes in the corresponding
parameter. There was no necessity to examine variations
with respect to β and ktl because one can always choose
units of time and mRNA concentration such that β = 1
and ktl = 1, i.e., changes in β or ktl can be mimicked by
changes in other parameters.
The average free p53 level is in general much more sen-
sitive to changes in γ, δ, kt and ι than to changes in α and
kD. The sensitivity with respect to variation of γ appears
to be very little for values in the range of 1-to 2-fold the
default value. This coincides with the onset of oscilla-
tions. In contrast, the peak p53 level retains its sensitivity
(Figure S4, additional file 2). That is, while the amplitude
of oscillations increases significantly the average does
not, a feature that arises due to the spikyness of the oscil-
lations. The physiological significance of this is unclear.
Overall, it is clear that stresses that affect only α or kD,
such as Nutlin, will have the least impact on average p53
level. For other stresses, the relative impact depends on
how many of the sensitive parameters they affect. Thus,
DNA damage and hypoxia, which each affect two sensi-
tive parameters, result in a relatively stronger response
than oncogene deregulation, which only affects one
parameter.
The effect of single nucleotide polymorphisms
Our model can also be used to examine the behaviour of
certain mutant cell lines. For instance, the G allele of the
mdm2  single nucleotide polymorphism 309 (SNP309)
results in an increased expression of mdm2 compared to
the T allele [35]. This corresponds to changing the initial
resting state from the one in Figure 2C to one with
increased  kt  (i.e., increased rate of transcription of
mdm2), as illustrated in Figure 4. The figure shows that,
in our model, for a given intensity of stress, the response
of a cell with the G allele is weaker. This suggests that
populations with a higher frequency of the G allele, such
as Caucasians (45% TT, 44% TG, 11% GG; as compared to
African Americans: 74% TT, 23% TG, 3% GG) should
exhibit a lower p53 level in response to stress. Assuming
that p53 level correlates with apoptosis, this would sug-
gest a lower incidence of apoptosis, and a higher fre-
q u e n c y  o f  t u m o u r  f o r m a t i o n .  T h i s  i s  i n d e e d  o b s e r v e d
when comparing apoptosis frequency in lymphocyte cell
lines from Caucasian and African American donors [36].
Figure 4 Effect of the mdm2 SNP309. The color map and the white 
dot are the same as in Figure 2B-D. In the presence of the mdm2 
SNP309 G allele, the resting state of the cell is shifted towards higher kt 
values, as indicated by the black dot. It is not known how much the 
SNP changes the kt value, but the qualitative behaviour can be predict-
ed: the same stress will lead to a weaker response for GG than for TT.
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Variability in the p53 response
Single-cell measurements of p53 oscillations in response
to various types of irradiation exhibit a fair amount of
variability in the response across different cells [21,31].
The deterministic simulations we have done cannot
address this issue, so stochastic simulations are required.
However, the numbers of p53 and Mdm2 molecules are
typically very large: Measured levels of p53 range from
17,000-200,000 molecules in different cell lines [17,37],
and the resting level of p53 in our model, ≈ 100 nM, cor-
responds to 50,000 molecules per cell (assuming the cell
is a sphere of radius around 6 μm). Such high numbers
mean that the noise due to stochasticity in production
and degradation of molecules is very small. Thus, the
result of stochastic simulations of our model using the
standard Gillespie algorithm [38] are indistinguishable
from the deterministic simulations. It is possible that
there are other sources that result in a higher noise in
cells. If we increase the noise in our Gillespie simulations
in an ad-hoc manner (we do this by arbitrarily assuming a
500-fold smaller cell volume, thereby decreasing the over-
all numbers of both p53 and Mdm2 proportionally; other
stochastic models [39] also seem to work with similarly
low numbers of p53 despite the measurements) then we
observe that the first peak position is quite robust to
noise, the second peak position varies a little more, while
the third peak position varies significantly (see Fig. 5).
This is exactly what has been observed in single-cell
experiments of the p53 response to ionizing radiation
[31]. On the basis of these stochastic simulations we
hypothesize that:
1. The variability in p53 response observed in [21,31] 
must originate from sources other than stochasticity 
in the production and degradation of molecules, 
because the numbers of involved molecules are rather 
large.
2. Increasing amounts of noise are likely to introduce 
more variability in the position of later p53 peaks than 
in earlier peaks, as observed.
However, a proper analysis of these hypotheses requires
a better knowledge of which sources of noise underly the
variability observed, so that they can be modelled accu-
rately.
Conclusions
Predictions from the model
The sensitivity analysis in Figure 3 shows which parame-
ters most affect the p53 level in our model. Combining
this information with a knowledge of which parameters
are affected by different stresses provides predictions
about which stresses will affect the p53 level the most.
One specific prediction is that around the onset of oscil-
lations, changes in γ result in large changes in peak p53
levels but hardly any change in average p53 levels.
The analysis also leads to a prediction of reduced p53-
dependent apoptosis in populations which have an
increased frequency of the G allele of the mdm2 SNP309
- a prediction that is confirmed by observations. In addi-
tion, if the increase in kt due to the SNP is sufficient, then
although p53 will be upregulated in response to stress,
oscillations will not occur (as can be seen from Figure 4).
This effect has also been observed experimentally [35].
The same analysis method can be used to predict the
effect of other SNPs as soon as one knows which parame-
ters (i.e., which molecular processes) they affect.
Finally, we note that the temporal dynamics of the p53
response to different stresses are also predictions of the
model that can be tested experimentally. To our knowl-
edge, single cell experiments examining the p53 dynamics
in response to hypoxia or oncogene deregulation have not
been done. Our model predicts that oscillations should
be observed in both cases, which tend to have longer time
periods than in response to DNA damage and with a par-
ticularly distinct time delay (and reduction of amplitude)
between the first and second peaks.
Extending the model
Our model could eventually be extended to cover other
stresses that trigger a p53 response as more data becomes
available. Nitric oxide (NO) is a free radical produced in
inflamed tissue which can trigger the p53 pathway by
phosphorylating p53 and thereby inhibiting its Mdm2-
mediated degradation [40]. Another example is ribonu-
cleotide depletion: cells suffering this undergo a revers-
ible p53-dependent cell cycle arrest [5]. How this happens
has not been fully worked out, but a hypothesis exists: the
depletion could cause a redistribution of p53 from cyto-
Figure 5 Effects of noise. Three independent stochastic runs using 
the Gillespie algorithm of the model's response to DNA damage. Mod-
el parameters are changed at time zero as in Fig. 2. Later peaks in p53 
level show more variability than earlier peaks. Molecule numbers were 
chosen small enough to achieve a visible amount of noise. Using real-
istic numbers makes the stochastic simulations indistinguishable from 
deterministic behaviour (see text and Figure S6 in additional file 2).
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plasm to the nucleus, where it can be transcriptionally
active [5]. Finally, heat shock can also trigger p53 but the
picture is rather complex and indecisive, involving vari-
ous chaperones and heat shock proteins [41-43]. Other
directions to extend the model are of course to include
other feedback loops and essential players in p53 regula-
tion, such as Wip1 [20] and MdmX [10], and to model the
connection between p53 levels and physiological behav-
iour more accurately as has been done for cell cycle arrest
in ref. [44].
Overall, we have shown that this kind of negative feed-
back loop, consisting of a relatively slow transciptional
activation on one leg of the loop, and an inhibition based
on fast complex formation on the other, can be designed
to respond specifically to a number of different input trig-
gers. This kind of negative feedback loop also occurs in
another important signalling pathway that is triggered by
hundreds of input signals, namely NF-κB signalling in the
immune system [45]. NF-κB is a transcription factor that
controls hundreds of downstream genes. It activates pro-
duction of IκBα, which binds to and inhibits the action of
NF-κB [46]. The resultant negative feedback loop exhibits
spiky oscillations [25,47] similar to the kind we observe in
the model presented here. Thus, our results might also
have relevance beyond p53.
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